investor briefcase

Annual Meeting - 2011 Notice of annual meeting of stockholders Form 10 K Annual Meeting Proxy Card Quarterly Shareholder Letters May 26, 2010 September 3, 2010 November 19, 2009 May 1, 2009 January 12, 2009 October 24, 2008 Analyst Reports November 15th, 2011, Zacks Small-Cap Research, IMMUNOCELLULAR THERAPEUTICS, LTD (OTCBB: IMUC) July 28th, 2011, Summer Street, IMMUNOCELLULAR THERAPEUTICS, LTD (OTCBB: IMUC) April 4th, 2011, Zacks Small-Cap Research, IMMUNOCELLULAR THERAPEUTICS, LTD (OTCBB: IMUC) March 22th, 2011, Dawson James Securities IMUC Initiation, IMMUNOCELLULAR THERAPEUTICS, LTD (OTCBB: IMUC) November 9, 2009, Griffin Securities, Inc., IMMUNOCELLULAR THERAPEUTICS, LTD (OTCBB: IMUC) September 14, 2009, Griffin Securities, Inc., Targeting Cancer Stem Cells, an Industry Report On April 27, 2009, Griffin Securities, Inc. initiated research coverage on ImmunoCellular Therapeutics (OTCBB:IMUC) with a BUY Rating and a 12-month price target of $2.50.

Disclaimer: ImmunoCellular Therapeutics, Ltd. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding ImmunoCellular Therapeutics, Ltd's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ImmunoCellular Therapeutics, Ltd or its management. ImmunoCellular Therapeutics, Ltd does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.